RETATRUTIDE
CLASSIFICATION: GIP/GLP-1/GLUCAGON RECEPTOR TRIAGONIST
ACTIVE SUBSTANCE: RETATRUTIDE
FORM: 2 ML VIAL x 10 MG
ACTIVE HALF-LIFE: ~ 6 DAYS
DOSAGE: 0.5 MG/WEEK
ACNE: N/A
WATER RETENTION: N/A
HBR: N/A
HEPATOTOXICITY: N/A
AROMATIZATION: N/A
MANUFACTURER: DRAGON PHARMA
RETATRUTIDE Detailed
Trusted Dragon Pharma Retatrutide Source
DragonPharma.net online store sells peptides, we have only original peptides, you can buy from us original Retatrutide by Dragon Pharma.
What is Retatrutide?
Introducing Retatrutide, a groundbreaking pharmaceutical innovation from Dragon Pharma with promising applications in the treatment of obesity and diabetes. Also recognized as the GGG Tri-agonist, GLP-1/GIP/glucagon tri-agonist, or LY3437943, this injectable medication shares similarities with well-established weight loss treatments such as tirzepatide and semaglutide but demonstrates enhanced effectiveness. When incorporated into a holistic approach involving a balanced diet, regular exercise, and lifestyle adjustments, Retatrutide exhibits the potential to significantly enhance weight loss outcomes and address associated comorbidities like diabetes and hypertension (high blood pressure).
Retatrutide, a revolutionary weight loss medication developed by Dragon Pharma, outshines its counterparts with superior efficacy. Operating through three key mechanisms, this innovative drug brings about therapeutic effects that redefine weight management:
Gastric Inhibitory Polypeptide Receptor (GIPR) Agonist: Functioning as a GIP receptor agonist, retatrutide excels in appetite suppression and preventing fat accumulation. This results in a reduction of energy intake and an increase in energy expenditure.
Glucagon-Like Peptide 1 Receptor (GLP-1R) Agonist: Retatrutide contributes to weight loss by enhancing blood sugar regulation. It achieves this by promoting increased insulin release from the pancreas while reducing the release of glucagon, a hormone that elevates blood sugar levels.
Glucagon Receptor (GR) Agonist: Acting as a GR agonist, retatrutide diminishes glucagon release, leading to improved blood sugar levels, reduced food intake, and heightened energy expenditure. The culmination of these effects results in effective weight loss.
Moreover, retatrutide plays a pivotal role in regulating blood sugar levels through its influence on insulin and glucagon. By functioning as both a GLP-1 agonist and GR agonist, it facilitates insulin release while curbing glucagon release, contributing to balanced blood sugar levels.
Beyond its prowess as a weight loss drug, retatrutide exhibits potential in addressing obesity-associated issues like hypertension. By modulating energy intake and expenditure, it not only promotes fat loss but may also contribute to reducing blood pressure, as studies suggest a correlation between weight loss and blood pressure reduction.
How is Retatrutide used?
As a novel drug in the fight against obesity, Retatrutide, currently under development by Dragon Pharma, is administered subcutaneously once weekly. The initial dose is 0.5 mg, with the flexibility to escalate to 1 mg, 2 mg, or 4 mg after 4 weeks based on individual response. The maximum weekly dosage stands at 12 mg.
Initiating with a conservative dose mitigates the risk of side effects, allowing for gradual adjustments based on individual tolerance. Should serious side effects arise, dose reduction or discontinuation is advised, prioritizing patient well-being throughout the treatment journey.
Adverse effects
In terms of side effects, retatrutide has demonstrated a remarkably low incidence. Reported instances include chest pain, depression, difficulty breathing, dizziness, dry mouth, fatigue, headache, irregular heartbeat, and swelling in the hands and feet. It's essential to note that these occurrences were infrequent, and their association with retatrutide remains uncertain.
Safety-wise, gastrointestinal-related events constitute the most common adverse effects, generally of mild nature and self-resolving. This aligns retatrutide's safety and tolerability profile with other incretin-based therapies, reinforcing its position as a well-tolerated option in weight management.
References
Please log in to write RETATRUTIDE review.
CLASSIFICATION: GLP-1 RECEPTOR AGONIST
ACTIVE SUBSTANCE: SEMAGLUTIDE
FORM: POWDER - 2 ML VIAL x 5 MG
ACTIVE HALF-LIFE: 7 DAYS
DOSAGE: 0.25 - 0.5 MG/WEEK
ACNE: NO
WATER RETENTION: NO
HBR: NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA, EUROPE
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: GLP-1 RECEPTOR AGONIST
ACTIVE SUBSTANCE: TIRZEPATIDE
FORM: POWDER - 2 ML VIAL x 5 MG/VIAL
ACTIVE HALF-LIFE: 5 DAYS
DOSAGE: 2.5 - 5 MG/WEEK
ACNE: NO
WATER RETENTION: NO
HBR: NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA, EUROPE
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: HUMAN PEPTIDE HORMONE
ACTIVE SUBSTANCE: EPHITALON ACETATE
FORM: 2 ML VIAL x 50 MG
ACTIVE HALF-LIFE: N/A
DOSAGE: MEN 5 MG-10 MG PER DAY
ACNE: NOT REPORTED
WATER RETENTION: MINIMAL
HBR: N/A
HEPATOTOXICITY: N/A
AROMATIZATION: N/A
MANUFACTURER: DRAGON PHARMA
LABORATORY TESTED: VIEW LAB RESULTS
DUAL GLUCAGON AGONIST; GLP-1 AGONIST
ACTIVE SUBSTANCE: 10 MG SURVODUTIDE
FORM: 2 ML VIAL
ACTIVE HALF-LIFE: 109-115 HOURS
DOSAGE: MEN 0.6-4.8 MG/WEEK
ACNE: PERHAPS
WATER RETENTION: NO
HBR: NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA, EUROPE
LABORATORY TESTED: VIEW LAB RESULTS
DUAL GLUCAGON AGONIST; GLP-1 AGONIST
ACTIVE SUBSTANCE: 10 MG MAZDUTIDE
FORM: 2 ML VIAL
ACTIVE HALF-LIFE: 158-180 HOURS
DOSAGE: MEN 3-9 MG/WEEK
ACNE: NO
WATER RETENTION: NO
HBR: NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA, EUROPE
LABORATORY TESTED: VIEW LAB RESULTS
DRUG CLASS: AMYLIN ANALOG
ACTIVE SUBSTANCE: 10 MG CAGRILINTIDE ACETATE
FORM: 2 ML VIAL
ACTIVE HALF-LIFE: 7-10 DAYS
DOSAGE: MEN 0.3-4.5 MG/WEEK
ACNE: NO
WATER RETENTION: NO
HBR: NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA, EUROPE
LABORATORY TESTED: VIEW LAB RESULTS
Dec 23, 2024 (08:00)
This product is fantastic for keeping my energy balanced and focus sharp. Retatrutide has improved my stamina, allowing me to handle tough workouts. It's a reliable source of motivation that ensures I stay active and achieve my fitness milestones.